Evidence map›Paper›PMID 21677065›Full record

ArticleJournal of clinical microbiology2011

Quantitation of Candida CFU in initial positive blood cultures.

Christopher D Pfeiffer, Gregory P Samsa, Wiley A Schell, L Barth Reller, John R Perfect, Barbara D Alexander

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Guideline
  3. Article
  4. Review
  5. Review
  6. Article
  7. Bacterial and fungal infections in infants born before 24 weeks' gestation: a review.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  8. Article
  9. Early-Onset Candidemia in Adult Intensive Care Units.Diagnostics (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Rapid and sensitive identification ofFrontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Epidemiology of Invasive Candidiasis.Clinical epidemiology · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher D PfeifferDepartments of Medicine, Duke University Medical Center (DUMC), Durham, North Carolina, USA. pfeiffer33@gmail.com
Gregory P Samsa
Wiley A Schell
L Barth Reller
John R Perfect
Barbara D Alexander

Funding

Pilot Project for the DTMI CRA ProgramUL1RR024128 · NCRR · DUKE UNIVERSITY · PI CALIFF, ROBERT M · 2006 to 2010
$48.1M
Microfluidic PCR Platform to Detect Microbial DNAU01AI066590 · NIAID · DUKE UNIVERSITY · PI MITCHELL, THOMAS G. · 2005 to 2009
$3.0M
Mid-Career Investigator Award: Preventing and Diagnosing Fungal DiseaseK24AI072522 · NIAID · DUKE UNIVERSITY · PI ALEXANDER, BARBARA D · 2007 to 2011
$583k
NCRR NIH HHS UL1 RR024128NCRR NIH HHS UL1RR024128NIAID NIH HHS K24 AI072522NIAID NIH HHS K24-AI072522NIAID NIH HHS U01 AI066590NIAID NIH HHS U01-AI066590
6 · The paper itself

Abstract

One potential limitation of DNA-based molecular diagnostic tests for Candida bloodstream infection (BSI) is organism burden, which is not sufficiently characterized. We hypothesized that the number of CFU per milliliter (CFU/ml) present in an episode of Candida BSI is too low for reliable DNA-based diagnostics. In this study, we determined Candida burden in the first positive blood culture and explored factors that affect organism numbers and patient outcomes. We reviewed records of consecutive patients with a positive blood culture for Candida in the lysis-centrifugation blood culture system (Isolator, Wampole Laboratories, Cranbury, NJ) from 1987 to 1991. Descriptive statistics and logistic regression analyses were performed. One hundred fifty-two episodes of Candida BSI were analyzed. Patient characteristics included adult age (72%), indwelling central venous catheters (83%), recent surgery (29%), neutropenia (24%), transplant (14%), and other immune suppression (21%). Rates of treatment success and 30-day mortality for candidemia were each 51%. The median CFU/ml was 1 (mode 0.1, range 0.1 to >1,000). In the multivariate analysis, pediatric patients were more likely than adults to have high organism burdens (odds ratio [OR], 10.7; 95% confidence interval [95% CI], 4.3 to 26.5). Initial organism density did not affect patient outcome. Candida CFU/ml in the first positive blood culture of a BSI episode varies greatly; >50% of cultures had ≤1 CFU/ml, a concentration below the experimental yeast cell threshold for reliable DNA-based diagnostics. DNA-based diagnostics for Candida BSI will be challenged by low organism density and the need for sufficient specimen volume; future research on alternate targets is warranted.

Indexed as

AdolescentAdultBloodCandidaCandidemiaChildChild, PreschoolColony Count, MicrobialFemaleHumansInfantMale

Identifiers

PMID21677065
PMCPMC3147732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.